共 50 条
- [1] Efficacy and safety of filgotinib in patients with Ulcerative Colitis stratified by age: Post hoc analysis of the phase 2b/3 SELECTION and SELECTIONLTE studies JOURNAL OF CROHNS & COLITIS, 2022, 16 : I085 - I087
- [2] Withdrawal and Re-treatment with Filgotinib in Ulcerative Colitis: Post Hoc Analyses of the Phase 2b/3 SELECTION and SELECTIONLTE Studies JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 54 - 64
- [3] Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 801 - 811
- [5] Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study JOURNAL OF CROHNS & COLITIS, 2021, 15 : S004 - S005
- [7] Efficacy of filgotinib in patients with Ulcerative Colitis by line of therapy in the phase 2b/3 SELECTION trial JOURNAL OF CROHNS & COLITIS, 2021, 15 : S024 - S025
- [8] Efficacy of Filgotinib in Patients with Ulcerative Colitis by Line of Therapy in the Phase 2b/3 SELECTION Trial JOURNAL OF CROHNS & COLITIS, 2023, 17 (08): : 1207 - 1216